Global Biomonitoring and Bioburden Testing Market Research Report 2023

SKU ID :QYR-23485516 | Published Date: 10-Apr-2023 | No. of pages: 86
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biomonitoring and Bioburden Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Culture Media and Reagents Kit 1.2.3 Instruments 1.2.4 PCR (Polymerase Chain Reaction) 1.2.5 Automated Microbial Identification Systems 1.2.6 Microscope 1.2.7 Others 1.3 Market by Application 1.3.1 Global Biomonitoring and Bioburden Testing Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Medical Devices Testing 1.3.3 Monitoring of Manufacturing Process 1.3.4 Environmental Monitoring 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Biomonitoring and Bioburden Testing Market Perspective (2018-2029) 2.2 Biomonitoring and Bioburden Testing Growth Trends by Region 2.2.1 Global Biomonitoring and Bioburden Testing Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Biomonitoring and Bioburden Testing Historic Market Size by Region (2018-2023) 2.2.3 Biomonitoring and Bioburden Testing Forecasted Market Size by Region (2024-2029) 2.3 Biomonitoring and Bioburden Testing Market Dynamics 2.3.1 Biomonitoring and Bioburden Testing Industry Trends 2.3.2 Biomonitoring and Bioburden Testing Market Drivers 2.3.3 Biomonitoring and Bioburden Testing Market Challenges 2.3.4 Biomonitoring and Bioburden Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Biomonitoring and Bioburden Testing Players by Revenue 3.1.1 Global Top Biomonitoring and Bioburden Testing Players by Revenue (2018-2023) 3.1.2 Global Biomonitoring and Bioburden Testing Revenue Market Share by Players (2018-2023) 3.2 Global Biomonitoring and Bioburden Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Biomonitoring and Bioburden Testing Revenue 3.4 Global Biomonitoring and Bioburden Testing Market Concentration Ratio 3.4.1 Global Biomonitoring and Bioburden Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biomonitoring and Bioburden Testing Revenue in 2022 3.5 Biomonitoring and Bioburden Testing Key Players Head office and Area Served 3.6 Key Players Biomonitoring and Bioburden Testing Product Solution and Service 3.7 Date of Enter into Biomonitoring and Bioburden Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Biomonitoring and Bioburden Testing Breakdown Data by Type 4.1 Global Biomonitoring and Bioburden Testing Historic Market Size by Type (2018-2023) 4.2 Global Biomonitoring and Bioburden Testing Forecasted Market Size by Type (2024-2029) 5 Biomonitoring and Bioburden Testing Breakdown Data by Application 5.1 Global Biomonitoring and Bioburden Testing Historic Market Size by Application (2018-2023) 5.2 Global Biomonitoring and Bioburden Testing Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Biomonitoring and Bioburden Testing Market Size (2018-2029) 6.2 North America Biomonitoring and Bioburden Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Biomonitoring and Bioburden Testing Market Size by Country (2018-2023) 6.4 North America Biomonitoring and Bioburden Testing Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Biomonitoring and Bioburden Testing Market Size (2018-2029) 7.2 Europe Biomonitoring and Bioburden Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Biomonitoring and Bioburden Testing Market Size by Country (2018-2023) 7.4 Europe Biomonitoring and Bioburden Testing Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Biomonitoring and Bioburden Testing Market Size (2018-2029) 8.2 Asia-Pacific Biomonitoring and Bioburden Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region (2018-2023) 8.4 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Biomonitoring and Bioburden Testing Market Size (2018-2029) 9.2 Latin America Biomonitoring and Bioburden Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Biomonitoring and Bioburden Testing Market Size by Country (2018-2023) 9.4 Latin America Biomonitoring and Bioburden Testing Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Biomonitoring and Bioburden Testing Market Size (2018-2029) 10.2 Middle East & Africa Biomonitoring and Bioburden Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2018-2023) 10.4 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Detail 11.1.2 Merck Business Overview 11.1.3 Merck Biomonitoring and Bioburden Testing Introduction 11.1.4 Merck Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) 11.1.5 Merck Recent Development 11.2 STERIS Laboratories 11.2.1 STERIS Laboratories Company Detail 11.2.2 STERIS Laboratories Business Overview 11.2.3 STERIS Laboratories Biomonitoring and Bioburden Testing Introduction 11.2.4 STERIS Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) 11.2.5 STERIS Laboratories Recent Development 11.3 Charles River Laboratories International 11.3.1 Charles River Laboratories International Company Detail 11.3.2 Charles River Laboratories International Business Overview 11.3.3 Charles River Laboratories International Biomonitoring and Bioburden Testing Introduction 11.3.4 Charles River Laboratories International Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) 11.3.5 Charles River Laboratories International Recent Development 11.4 Lumex Instruments 11.4.1 Lumex Instruments Company Detail 11.4.2 Lumex Instruments Business Overview 11.4.3 Lumex Instruments Biomonitoring and Bioburden Testing Introduction 11.4.4 Lumex Instruments Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) 11.4.5 Lumex Instruments Recent Development 11.5 Pacific BioLabs 11.5.1 Pacific BioLabs Company Detail 11.5.2 Pacific BioLabs Business Overview 11.5.3 Pacific BioLabs Biomonitoring and Bioburden Testing Introduction 11.5.4 Pacific BioLabs Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) 11.5.5 Pacific BioLabs Recent Development 11.6 Sigma-Aldrich 11.6.1 Sigma-Aldrich Company Detail 11.6.2 Sigma-Aldrich Business Overview 11.6.3 Sigma-Aldrich Biomonitoring and Bioburden Testing Introduction 11.6.4 Sigma-Aldrich Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) 11.6.5 Sigma-Aldrich Recent Development 11.7 WuXi AppTec 11.7.1 WuXi AppTec Company Detail 11.7.2 WuXi AppTec Business Overview 11.7.3 WuXi AppTec Biomonitoring and Bioburden Testing Introduction 11.7.4 WuXi AppTec Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) 11.7.5 WuXi AppTec Recent Development 11.8 Dynatec Labs 11.8.1 Dynatec Labs Company Detail 11.8.2 Dynatec Labs Business Overview 11.8.3 Dynatec Labs Biomonitoring and Bioburden Testing Introduction 11.8.4 Dynatec Labs Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) 11.8.5 Dynatec Labs Recent Development 11.9 Nelson Laboratories 11.9.1 Nelson Laboratories Company Detail 11.9.2 Nelson Laboratories Business Overview 11.9.3 Nelson Laboratories Biomonitoring and Bioburden Testing Introduction 11.9.4 Nelson Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) 11.9.5 Nelson Laboratories Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Biomonitoring and Bioburden Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Culture Media and Reagents Kit Table 3. Key Players of Instruments Table 4. Key Players of PCR (Polymerase Chain Reaction) Table 5. Key Players of Automated Microbial Identification Systems Table 6. Key Players of Microscope Table 7. Key Players of Others Table 8. Global Biomonitoring and Bioburden Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 9. Global Biomonitoring and Bioburden Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 10. Global Biomonitoring and Bioburden Testing Market Size by Region (2018-2023) & (US$ Million) Table 11. Global Biomonitoring and Bioburden Testing Market Share by Region (2018-2023) Table 12. Global Biomonitoring and Bioburden Testing Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 13. Global Biomonitoring and Bioburden Testing Market Share by Region (2024-2029) Table 14. Biomonitoring and Bioburden Testing Market Trends Table 15. Biomonitoring and Bioburden Testing Market Drivers Table 16. Biomonitoring and Bioburden Testing Market Challenges Table 17. Biomonitoring and Bioburden Testing Market Restraints Table 18. Global Biomonitoring and Bioburden Testing Revenue by Players (2018-2023) & (US$ Million) Table 19. Global Biomonitoring and Bioburden Testing Market Share by Players (2018-2023) Table 20. Global Top Biomonitoring and Bioburden Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomonitoring and Bioburden Testing as of 2022) Table 21. Ranking of Global Top Biomonitoring and Bioburden Testing Companies by Revenue (US$ Million) in 2022 Table 22. Global 5 Largest Players Market Share by Biomonitoring and Bioburden Testing Revenue (CR5 and HHI) & (2018-2023) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Biomonitoring and Bioburden Testing Product Solution and Service Table 25. Date of Enter into Biomonitoring and Bioburden Testing Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Biomonitoring and Bioburden Testing Market Size by Type (2018-2023) & (US$ Million) Table 28. Global Biomonitoring and Bioburden Testing Revenue Market Share by Type (2018-2023) Table 29. Global Biomonitoring and Bioburden Testing Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 30. Global Biomonitoring and Bioburden Testing Revenue Market Share by Type (2024-2029) Table 31. Global Biomonitoring and Bioburden Testing Market Size by Application (2018-2023) & (US$ Million) Table 32. Global Biomonitoring and Bioburden Testing Revenue Market Share by Application (2018-2023) Table 33. Global Biomonitoring and Bioburden Testing Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 34. Global Biomonitoring and Bioburden Testing Revenue Market Share by Application (2024-2029) Table 35. North America Biomonitoring and Bioburden Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 36. North America Biomonitoring and Bioburden Testing Market Size by Country (2018-2023) & (US$ Million) Table 37. North America Biomonitoring and Bioburden Testing Market Size by Country (2024-2029) & (US$ Million) Table 38. Europe Biomonitoring and Bioburden Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 39. Europe Biomonitoring and Bioburden Testing Market Size by Country (2018-2023) & (US$ Million) Table 40. Europe Biomonitoring and Bioburden Testing Market Size by Country (2024-2029) & (US$ Million) Table 41. Asia-Pacific Biomonitoring and Bioburden Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 42. Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region (2018-2023) & (US$ Million) Table 43. Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region (2024-2029) & (US$ Million) Table 44. Latin America Biomonitoring and Bioburden Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 45. Latin America Biomonitoring and Bioburden Testing Market Size by Country (2018-2023) & (US$ Million) Table 46. Latin America Biomonitoring and Bioburden Testing Market Size by Country (2024-2029) & (US$ Million) Table 47. Middle East & Africa Biomonitoring and Bioburden Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 48. Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2024-2029) & (US$ Million) Table 50. Merck Company Detail Table 51. Merck Business Overview Table 52. Merck Biomonitoring and Bioburden Testing Product Table 53. Merck Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) & (US$ Million) Table 54. Merck Recent Development Table 55. STERIS Laboratories Company Detail Table 56. STERIS Laboratories Business Overview Table 57. STERIS Laboratories Biomonitoring and Bioburden Testing Product Table 58. STERIS Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) & (US$ Million) Table 59. STERIS Laboratories Recent Development Table 60. Charles River Laboratories International Company Detail Table 61. Charles River Laboratories International Business Overview Table 62. Charles River Laboratories International Biomonitoring and Bioburden Testing Product Table 63. Charles River Laboratories International Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) & (US$ Million) Table 64. Charles River Laboratories International Recent Development Table 65. Lumex Instruments Company Detail Table 66. Lumex Instruments Business Overview Table 67. Lumex Instruments Biomonitoring and Bioburden Testing Product Table 68. Lumex Instruments Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) & (US$ Million) Table 69. Lumex Instruments Recent Development Table 70. Pacific BioLabs Company Detail Table 71. Pacific BioLabs Business Overview Table 72. Pacific BioLabs Biomonitoring and Bioburden Testing Product Table 73. Pacific BioLabs Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) & (US$ Million) Table 74. Pacific BioLabs Recent Development Table 75. Sigma-Aldrich Company Detail Table 76. Sigma-Aldrich Business Overview Table 77. Sigma-Aldrich Biomonitoring and Bioburden Testing Product Table 78. Sigma-Aldrich Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) & (US$ Million) Table 79. Sigma-Aldrich Recent Development Table 80. WuXi AppTec Company Detail Table 81. WuXi AppTec Business Overview Table 82. WuXi AppTec Biomonitoring and Bioburden Testing Product Table 83. WuXi AppTec Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) & (US$ Million) Table 84. WuXi AppTec Recent Development Table 85. Dynatec Labs Company Detail Table 86. Dynatec Labs Business Overview Table 87. Dynatec Labs Biomonitoring and Bioburden Testing Product Table 88. Dynatec Labs Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) & (US$ Million) Table 89. Dynatec Labs Recent Development Table 90. Nelson Laboratories Company Detail Table 91. Nelson Laboratories Business Overview Table 92. Nelson Laboratories Biomonitoring and Bioburden Testing Product Table 93. Nelson Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2018-2023) & (US$ Million) Table 94. Nelson Laboratories Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Global Biomonitoring and Bioburden Testing Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Biomonitoring and Bioburden Testing Market Share by Type: 2022 VS 2029 Figure 3. Culture Media and Reagents Kit Features Figure 4. Instruments Features Figure 5. PCR (Polymerase Chain Reaction) Features Figure 6. Automated Microbial Identification Systems Features Figure 7. Microscope Features Figure 8. Others Features Figure 9. Global Biomonitoring and Bioburden Testing Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 10. Global Biomonitoring and Bioburden Testing Market Share by Application: 2022 VS 2029 Figure 11. Medical Devices Testing Case Studies Figure 12. Monitoring of Manufacturing Process Case Studies Figure 13. Environmental Monitoring Case Studies Figure 14. Biomonitoring and Bioburden Testing Report Years Considered Figure 15. Global Biomonitoring and Bioburden Testing Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 16. Global Biomonitoring and Bioburden Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 17. Global Biomonitoring and Bioburden Testing Market Share by Region: 2022 VS 2029 Figure 18. Global Biomonitoring and Bioburden Testing Market Share by Players in 2022 Figure 19. Global Top Biomonitoring and Bioburden Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomonitoring and Bioburden Testing as of 2022) Figure 20. The Top 10 and 5 Players Market Share by Biomonitoring and Bioburden Testing Revenue in 2022 Figure 21. North America Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. North America Biomonitoring and Bioburden Testing Market Share by Country (2018-2029) Figure 23. United States Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Canada Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. Europe Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Europe Biomonitoring and Bioburden Testing Market Share by Country (2018-2029) Figure 27. Germany Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. France Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. U.K. Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Italy Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Russia Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Nordic Countries Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Asia-Pacific Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Asia-Pacific Biomonitoring and Bioburden Testing Market Share by Region (2018-2029) Figure 35. China Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Japan Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. South Korea Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Southeast Asia Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. India Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Australia Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Latin America Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Latin America Biomonitoring and Bioburden Testing Market Share by Country (2018-2029) Figure 43. Mexico Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Brazil Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Middle East & Africa Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Middle East & Africa Biomonitoring and Bioburden Testing Market Share by Country (2018-2029) Figure 47. Turkey Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. Saudi Arabia Biomonitoring and Bioburden Testing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 49. Merck Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2018-2023) Figure 50. STERIS Laboratories Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2018-2023) Figure 51. Charles River Laboratories International Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2018-2023) Figure 52. Lumex Instruments Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2018-2023) Figure 53. Pacific BioLabs Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2018-2023) Figure 54. Sigma-Aldrich Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2018-2023) Figure 55. WuXi AppTec Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2018-2023) Figure 56. Dynatec Labs Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2018-2023) Figure 57. Nelson Laboratories Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2018-2023) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed
Merck STERIS Laboratories Charles River Laboratories International Lumex Instruments Pacific BioLabs Sigma-Aldrich WuXi AppTec Dynatec Labs Nelson Laboratories
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients